The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Hagen B. Huttner - , Friedrich-Alexander University Erlangen-Nürnberg, TUD Dresden University of Technology, Heidelberg University  (Author)
  • Peggy Janich - , TUD Dresden University of Technology (Author)
  • Martin Köhrmann - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • József Jászai - , Research Group Tissue Engineering (Author)
  • Florian Siebzehnrubl - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Ingmar Blümcke - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Meinolf Suttorp - , TUD Dresden University of Technology (Author)
  • Manfred Gahr - , TUD Dresden University of Technology (Author)
  • Daniela Kuhnt - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Christopher Nimsky - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Dietmar Krex - , Department of Neurosurgery (Author)
  • Gabriele Schackert - , TUD Dresden University of Technology (Author)
  • Kai Löwenbrück - , TUD Dresden University of Technology (Author)
  • Heinz Reichmann - , Department of Neurology (Author)
  • Eric Jüttler - , Heidelberg University  (Author)
  • Werner Hacke - , Heidelberg University  (Author)
  • Peter D. Schellinger - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Stefan Schwab - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Michaela Wilsch-Bräuninger - , Max Planck Institute of Molecular Cell Biology and Genetics (Author)
  • Anne Marie Marzesco - , Max Planck Institute of Molecular Cell Biology and Genetics (Author)
  • Denis Corbeil - , Research Group Tissue Engineering (Author)

Abstract

Cerebrospinal fluid (CSF) is routinely used for diagnosing and monitoring neurological diseases. The CSF proteins used so far for diagnostic purposes (except for those associated with whole cells) are soluble. Here, we show that human CSF contains specific membrane particles that carry prominin-1/CD133, a neural stem cell marker implicated in brain tumors, notably glioblastoma. Differential and equilibrium centrifugation and detergent solubility analyses showed that these membrane particles were similar in physical properties and microdomain organization to small membrane vesicles previously shown to be released from neural stem cells in the mouse embryo. The levels of membrane particle-associated prominin-1/CD133 declined during childhood and remained constant thereafter, with a remarkably narrow range in healthy adults. Glioblastoma patients showed elevated levels of membrane particle-associated prominin-1/CD133, which decreased dramatically in the final stage of the disease. Hence, analysis of CSF for membrane particles carrying the somatic stem cell marker prominin-1/CD133 offers a novel approach for studying human central nervous system disease.

Details

Original languageEnglish
Pages (from-to)698-705
Number of pages8
JournalStem Cells
Volume26
Issue number3
Publication statusPublished - Mar 2008
Peer-reviewedYes

External IDs

researchoutputwizard legacy.publication#18900
researchoutputwizard legacy.publication#19198
researchoutputwizard legacy.publication#19290
researchoutputwizard legacy.publication#24566
Scopus 43049120703
researchoutputwizard legacy.publication#25447
PubMed 18096722
ORCID /0000-0003-1181-3659/work/142252204

Keywords

Sustainable Development Goals

Keywords

  • Glioma, Human hematopoietic stem cells, Malignancy, Nervous system, Somatic stem cells